SARS-CoV-2 Antigen Rapid Test
Uses nasal swab specimens from individuals suspected of active COVID-19 by their doctor within the first seven days of the onset of symptoms.
Uses nasal swab specimens from individuals suspected of active COVID-19 by their doctor within the first seven days of the onset of symptoms.
• Single-well, triple target assay covering high conserved regions within N, E and ORF 1ab gene for high specificity.
• Full-process controls with negative, positive and internal controls.
• Qualitative detection of nucleic acids from SARS-CoV-2
Contact us
|
Features |
Specifications |
|
Technology |
Real-Time reverse transcription polymerase chain reaction(Rrt-PCR) |
|
Target Region |
N,E,ORF1ab |
|
Specimen Type |
Oropharyngeal swab, nasopharyngeal swab and deep cough sputum |
|
Internal Control |
Yes |
|
Minimum Sample Volume |
200 µl |
|
Test Duration |
90 minutes |
|
Limit of Detection |
500 copies/mL |
|
Precision of In-batch and batch(CV) |
＜5% |
|
Positive Percent Agreement |
97.46% (95%CI:92.75%-99.47%) |
|
Negative Percent Agreement |
98.26%(95%CI:94.99%-99.64%) |
|
Accuracy |
97.93%(95%CI:95.56%-99.24%) |
|
Storage Temperature |
-20±5 ℃ |
|
Package Size |
32 Tests/Kit |
Cat. No. | Product | Size |
P131-1591 | SARS-CoV-2 RT-PCR Test Kit | 32 Tests/Kit |
